-
Analyst Coverage
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.’s financial performance into perspective.
Analyst Coverage
Robert Hazlett
Bank of MontrealDavid Moskowitz/James Molloy
Caris & CompanyIan Sanderson
Cowen SecuritiesEnzon Pharmaceuticals, Inc. is currently followed by the brokerage firms listed above; this list may not be complete and is subject to change as firms add or delete coverage of Enzon. Please note that any opinions, estimates or forecasts regarding Enzon's historical or predicted performance made by the analysts at these firms are theirs alone and do not represent opinions, forecasts or predictions of Enzon, Inc or its management. Enzon is providing this listing as a service to its stockholders, and does not by listing these firms imply its endorsement of or concurrence with such information,conclusions or recommendations. Interested persons must obtain copies of analysts' reports on their own; Enzon does not distribute these reports. Various of these firms may be market-makers in Enzon stock and/or hold other long or short positions in the stock, and may provide compensated services to Enzon.
(ENZN) NASDAQ Last Trade 9.82 Change(%) 
+0.01 Volume 265586 1:22 PM - Mar 09, 2010
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | | +0.01 | |
| Volume | 265586 | ||
| 1:22 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
02-13-2009
Enzon to Release Fourth Quarte...
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
08-11-2008
Enzon Pharmaceuticals Announce...
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business -- -
03-17-2008
Enzon's PEG-SN38 Featured in C...
Enzon's PEG-SN38 Featured in Clinical Cancer Research
-
12-31-1969
Enzon Reports Strong First Qua...
Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure-- -
04-23-2009
Enzon Continues to Improve its...
Enzon Continues to Improve its Capital Structure
-- Company repurchased $17.5 million of its outstanding debt at a discount to par-- -
11-05-2008
Enzon Reports Solid Third Quar...
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business -- -
08-11-2008
Enzon Pharmaceuticals Announce...
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business --